adMare BioInnovations Welcomes 22 Influential Life Sciences Leaders to Cohort VI of the adMare Academy Executive Institute

Vancouver, BC, Toronto, ON, and Montreal, QC (November 28, 2023) – adMare BioInnovations (adMare) is pleased to welcome 22 life sciences leaders to Cohort VI of the adMare Academy’s Executive Institute.  

The adMare Academy’s high-value, high-impact talent development programs build the essential personnel needed to drive the Canadian life sciences ecosystem. The Executive Institute is an eight-month, custom-designed executive development program. During the program, professionals in the life sciences sector develop their leadership abilities in collaboration with industry peers, benefiting from their collective experiences within the Canadian life sciences landscape. Through executive dinners and optional conferences, hosted by prominent industry collaborators BIOTECanada and Bloom Burton & Co., participants build new connections, deepen relationships, and strengthen their networks. 

“The adMare Academy is delighted to once again have a robust cohort of life science leaders in our Executive Institute,” remarked Kristy Lonergan, Senior Director of the adMare Academy. “We have learned from almost 100 alumni that the essence of the program is rooted in the rich interactions among high potential colleagues, and we are exceptionally pleased to see this continue with the calibre and diversity of Cohort VI." 

The members of Cohort VI of the Executive Institute are: 

• Rodrigo Arancibia, Senior Director, Government of Canada, Department of Innovation, Science and Economic Development 
• Hugo Bohorquez, Research Scientist, Ontario Institute for Cancer Research 
• Carl Duda, Business Unit Head, Hematology Oncology Canada, Jazz Pharmaceuticals 
• Sue Evans, Senior Vice President, Global Regulatory Affairs, Aurinia Pharmaceuticals Inc. 
• Raminder Gill, Senior Director, Strategy & Business Development, Ventus Therapeutics 
• Andre Giroux, Senior Director, HR and Operations, NuChem Sciences Inc. 
• Stephen Hanson, Business Development Director, Spiderwort Inc 
• Tyler Harrison, Director of Chemistry, Chinook Therapeutics, A Novartis Company 
• Tiffany Hingsberg, Director, Project Management & Operational Excellence, Resilience Biotechnologies Inc. 
• Claudia Hui, Vice President, Investment Banking, Bloom Burton & Co. 
• Eric Lee, Business Development Director, Novocol Pharma 
• Kim Lucas, Senior Vice President, Sales, North America, STEMCELL Technologies 
• Muhammad Memon, Director of Finance, Microbion Pharma Corporation 
• Dana Packer, Director, Sales and Marketing, FORUS Therapeutics Inc. 
• Stephanie Page, Medical Science Liaison (MSL) Manager, Novartis 
• Ryan Philippe, Director, Strategic Partnerships and Innovation, Genome Canada 
• David Powell, Vice President, Therapeutic Discovery, Variant Bio 
• Kristyn Power, Program Director, Canada, Northwest Biotherapeutics, Inc. 
• Jennifer Quizi, Director, Biotherapeutics Manufacturing Centre- Virus Manufacturing Facility, Ottawa Hospital Research Institute 
• Carla Spina, CEO & Co-Founder, Noa Therapeutics Inc 
• Ryan Ward, Medical Director, Gastroenterology, Takeda Canada 
• Julianna Weber, Director, Clinical Affairs, Applied Pharmaceutical Innovation 

Collectively, spanning the five preceding cohorts, the Executive Institute has trained 89 life sciences leaders impacting 95 organizations. Among former program participants, 96% are employed in the Canadian life sciences industry. 

adMare acknowledges diversity as a pillar of strength within Canada and is committed to leveraging the adMare Academy programs to bridge the gender gap in leadership roles and create pathways for underrepresented groups — notably, 54% of participants in the previous cohorts of the program identify as women. 

-30- 

Media Contact  
Mounia Azzi  
Vice President, Corporate Development  
adMare BioInnovations  
mazzi@admarebio.com 

About adMare BioInnovations  

With a wealth of globally-competitive scientific discovery, Canada is primed to lead the life sciences world. To make this a reality, at adMare BioInnovations, we use our scientific and commercial expertise, specialized R&D infrastructure, and seed capital to build strong life sciences companies, robust ecosystems and industry-ready talent — and re-invest our returns back into the Canadian industry to ensure it is sustained for the long-term. As part of our commitment to build talent, we have created the adMare Academy, dedicated to providing the specialized training required to foster the next generation of highly qualified personnel who will drive the growth of Canadian life science companies. The adMare Academy has trained more than 500 alumni — 94% of whom are employed in the life sciences industry.